Retinal Blood Flow in Diabetes

REFERENCES

• Rosen P, Ballhausen T, Stocklauser K. Impairment of endothelium dependent relaxation in the diabetic rat heart: mechanisms and implications. Diabetes Res Clin Pract 1996; 31: S143–S155
   Google Scholar
• Johnstone M T, Creager S J, Scales K M, Cusco J A, Lee B K, Creager M A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993; 88: 2510–2516
   PubMed Web of Science ®Google Scholar
• Takagi C, Bursell S E, Lin Y W, Takagi H, Duh E, Jiang Z, Clermont A C, King G L. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci 1996; 37: 2504–2518
   PubMed Web of Science ®Google Scholar
• Stehouwer C D, Lambert J, Donker A J, van Hinsbergh V W. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34: 55–68
   PubMed Web of Science ®Google Scholar
• Baynes J W, Thorpe S R. The role of oxidative stress in diabetic complications. Curr Opin Endocrinol 1996; 3: 277–284
   Google Scholar
• Giugliano D, Cerellio A, Paolisso G. Diabetes mellitus, hypertension and cardiovascular disease: which role for oxidative stress. Metabolism 1995; 44: 363–368
   PubMed Web of Science ®Google Scholar
• Giugliano D, Cerellio A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257–265
   PubMed Web of Science ®Google Scholar
• Asahina T, Kashiwagi A, Nishio Y, Ikebuchi M, Harada N, Tanaka Y, Takagi Y, Saeki Y, Kikkawa R, Shigeta Y. Impaired activation of glucose oxidation and NADH supply in human endothelial cells exposed to H2O2 in high glucose medium. Diabetes 1995; 44: 520–526
   PubMed Web of Science ®Google Scholar
• Elliott T G, Cockcroft J R, Groop P H, Viberti G C, Ritter J M. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Colch) 1993; 85: 687–693
   Google Scholar
• Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90: 2548–2554
   PubMed Web of Science ®Google Scholar
• Williams S B, Cusco J A, Roddy M A, Johnstone M T, Creager M A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27: 567–574
   PubMed Web of Science ®Google Scholar
• Williams S B, Goldfine A B, Timimi F K, Ting H H, Roddy M A, Simonson D C, Creager M A. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695–1701
   PubMed Web of Science ®Google Scholar
• Bursell S E, Clermont A C, Shiba T, King G L. Evaluating retinal blood flow using video fluorescein angiography in control and diabetic rats. Curr Eye Res 1992; 11: 287–295
   PubMed Web of Science ®Google Scholar
• Clermont A C, Brittis M, Shiba T, McGovern T, King G L, Bursell S E. Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci 1994; 35: 981–990
   PubMed Web of Science ®Google Scholar
• Halvorsen Y C, Bursell S E, Wilkison W O, Clermont A C, Brittis M, McGovern T, Spiegelman B M. Vasodilation of rat retinal microvessels induced by monobutyrin: disregulation in diabetes. J Clin Invest 1993; 92: 2872–2876
   Google Scholar
• Shiba T, Inoguchi T, Sportsman J R, Heath W F, Bursell S E, King G L. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 1993; 265(28)E783–E793
   Google Scholar
• Higashi S, Clermont A C, Dhir V, Bursell S E. Reversibility of retinal blood flow abnormalities is disease duration dependent in diabetic rats. Diabetes 1998; 47(4)653–659
   Google Scholar
• Takagi C, King G L, Clermont A C, Cummins D R, Takagi H, Bursell S E. Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an α -glucosidase inhibitor. Curr Eye Res 1995; 14: 741–749
   PubMed Web of Science ®Google Scholar
• King G L, Shiba T, Oliver J, Inoguchi T, Bursell S E. Cellular and molecular abnormalities in the vascular endothelium of Diabetes Mellitus. Annu Rev Med 1994; 45: 179–188
   PubMed Web of Science ®Google Scholar
• Bursell S E, Takagi C, Clermont A C, Takagi H, Mori F, Ishii H, King G L. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. Invest Ophthalmol Vis Sci 1997; 38: 2711–2720
   PubMed Web of Science ®Google Scholar
• King G L, Takahara H, Kagokawa H, Clermont A C, Bursell S E, Rhodes C L. Demonstration of protein kinase C β isoform in the regulation of retinal blood flow by gene transfer. Invest Ophthalmol Vis Sci 1999; 40: S492, (Abstr)
   Google Scholar
• Ishii H, Jirousek M R, Koya D, Takagi C, Xia P, Clermont A C, Bursell S E, Kern T S, Ballas M, Heath W F, Stramm L E, Feener E P, King G L. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 1996; 272: 728–731
   PubMed Web of Science ®Google Scholar
• Takahara N, Clermont A C, Kagokawa H, Takahara H, Kurihara H, Bursell S E, King G L. Transgenic mice overexpressing protein kinase C β isoform mimicked the early vascular changes in diabetes. Diabetes 1999; 48: A138, (Abstr)
   Web of Science ®Google Scholar
• Takagi C, King G L, Takagi H, Lin Y W, Clermont A C, Bursell S E. Endothelin-1 (ET-1)'s action via endothelin (ETA) receptors is a primary mechanism modulating retinal circulatory response to hyperoxia. Invest Ophthalmol Vis Sci 1996; 37: 2099–2109
   PubMed Web of Science ®Google Scholar
• Takagi C, Bursell S E, Lin Y W, Takagi H, Duh E, Jiang Z, Clermont A C, King G L. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthamol Vis Sci 1996; 37: 2504–2518
   PubMed Web of Science ®Google Scholar
• Bursell S E, Clermont A C, Oren B, King G L. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci 1995; 36: 596–607
   PubMed Web of Science ®Google Scholar
• Yokota T, Ma R C, Park J Y, Isshiki K, Sotiropoulos K B, Rauniyar R K, Bornfeldt K E, King G L. Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes 2003; 52(3)838–845
   Google Scholar
• Mori F, King G L, Clermont A C, Bursell D K, Bursell S E. Endothelin-3 (ET-3) regulation of retinal hemodynamics in nondiabetic and diabetic rats. Invest Ophthalmol Vis Sci 2000; 41: 3955–3962
   Google Scholar
• Wilkinson-Berka J L. Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol 2006; 38: 752–765
   PubMed Web of Science ®Google Scholar
• Luksch A, Wimpissinger B, Polak K, Jandrasits K, Schmetterer L. ETa-receptor blockade, but not ACE inhibition, blunts retinal vessel response during isometric exercise. Am J Physiol Heart Circ Physiol 2006; 290: H1693–H1698
   Google Scholar
• Ebrahimian T G, Tamarat R, Clerque M, Duriez M, Levy B I, Silvestre J S. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arterioscler Thromb Vasc Biol 2005; 25: 65–70
   PubMed Web of Science ®Google Scholar
• Okada Y, Yamanaka I, Sakamoto T, Hata Y, Sassa Y, Yoshikawa H, Fujisawa K, Ishibashi T, Inomaka H. Increased expression of angiotensin-converting enzyme activity in retinas of diabetic rats. Jpn J Ophthalmol 2001; 45: 585–591
   Google Scholar
• Sodhi C P, Kanwar Y S, Sahai A. Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells. Am J Physiol Heart Circ Physiol 2003; 284: H846–H852
   Google Scholar
• Horio N, Clermont A C, Abiko A, Abiko T, Shoelson B D, Bursell S E, Feener E P. Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilation in normotensive diabetic rats. Diabetologia 2004; 47: 113–123
   Web of Science ®Google Scholar
• Bursell S E, Mori F, Clermont A C, Koya D, King G L. Nitric oxide (NO) mediation of retinal circulation in diabetic and nondiabetic rats. Invest Ophthalmol Vis Sci 1997; 38: S1135, (Abstr)
   Google Scholar
• Clermont A, Takahara H, Kagokawa H, Jiang Z, Feener E, Bursell S E. In vivo transfection of endothelial nitric oxide synthase (eNOS) via adenovirus infection in diabetic rats enhances retinal hemodynamics. Invest Ophthalmol Vis Sci 1999; 40: S680, (Abstr)
   Google Scholar
• Bank N, Aynedjian H S. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993; 43: 1306–1312
   PubMed Web of Science ®Google Scholar
• Sharma K, Danoff T M, DePiero A, Ziyadeh F N. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation by protein kinase C. Biochem Biophys Res Commun 1995; 207: 80–88
   PubMed Web of Science ®Google Scholar
• Joussen A M, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q, Moromizato Y, Bursell S E, Wiegand S J, Rudge J, Yancopoulos G D, Adamis A P. Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002; 160: 1683–1693
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Khosrof S, Bursell S E, Rohan R, Murata T, Clermont A C, Aiello L P, Ogura Y, Adamis A P. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999; 96: 10836–10841
   PubMed Web of Science ®Google Scholar
• Barouch F C, Miyamoto K, Allport J R, Fujita K, Bursell S E, Aiello L P, Luscinskas F W, Adamis A P. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 2000; 41: 1153–1158
   PubMed Web of Science ®Google Scholar
• Joussen A M, Murata T, Tsujikawa A, Kirchhof B, Bursell S E, Adamis A P. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 2001; 158: 147–152
   PubMed Web of Science ®Google Scholar
• Abiko T, Abiko A, Clermont A C, Shoelson B, Horio N, Takahashi J, Adamis A P, King G L, Bursell S E. Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 2003; 52: 829–837
   PubMed Web of Science ®Google Scholar
• Bursell S E, Clermont A C, Kinsley B T, Simonson D C, Aiello L M, Wolpert H A. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy: a video fluorescein angiographic study. Invest Ophthalmol Vis Sci 1996; 37: 886–897
   PubMed Web of Science ®Google Scholar
• Grunwald J E, Riva C E, Sinclair S H, Brucker A J, Petrig B L. Laser Doppler velocimetry study of retinal circulation in diabetes mellitus. Arch Ophthalmol 1986; 104: 991–996
   PubMedGoogle Scholar
• Kohner E M, Hamilton A MP, Saunders S J, Sutcliffe B A, Bulpitt C J. The retinal blood flow in diabetes. Diabetologia 1975; 11: 27–33
   PubMedGoogle Scholar
• Feke G T, Buzney S M, Ogasawara H, Fujio N, Goger D G, Spack N P, Gabbay K H. Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci 1994; 35: 2968–2975
   PubMed Web of Science ®Google Scholar
• Grunwald J E, DuPont J, Riva C E. Retinal hemodynamics in patients with early diabetes mellitus. Br J Ophthalmol 1996; 80: 327–331
   PubMed Web of Science ®Google Scholar
• Bertram B, Wolf S, Fiehofer S, Schulte K, Arend O, Reim M. Retinal circulation times in diabetes mellitus type 1. Br J Ophthalmol 1991; 75: 462–465
   PubMed Web of Science ®Google Scholar
• Grunwald J E, Riva C E, Baine J, Brucker J. Total retinal volumetric flow rate in diabetic patients with poor diabetic control. Invest Ophthalmol Vis Sci 1992; 33: 356–363
   PubMed Web of Science ®Google Scholar
• Kawagishi T, Hishizawa Y, Emoto M, Konishi T, Maekawa K, Hagiwara S, Okuno Y, Inada H, Isshiki G, Mori H. Impaired retinal artery blood flow in IDDM patients before clinical manifestations of diabetic retinopathy. Diabetes Care 1995; 18: 1544–1549
   PubMed Web of Science ®Google Scholar
• Clermont A C, Aiello L P, Mori F, Aiello L M, Bursell S E. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997; 124: 433–446
   PubMed Web of Science ®Google Scholar
• Skovborg F, Nielsen A, Lauritzen E, Hartkopp D. Diameter of retinal vessels in diabetic and normal subjects. Diabetes 1969; 18: 292–298
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986
   PubMed Web of Science ®Google Scholar
• Properzi G, Terenghi G, Gu X H, Poccia G, Pasqua R, Francavilla S, Polak J M. Early increase precedes a depletion of endothelin-1 but not von Willebrand factor in cutaneous microvessels in diabetic patients. J Pathol 1995; 175: 243–252
   PubMedGoogle Scholar
• Hata Y, Clermont A, Yamauchi T, Pierce E A, Suzuma I, Kagokawa H, Yoshikawa H, Robinson G S, Ishibashi T, Hashimoto T, Umeda F, Bursell S E, Aiello L P. Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. J Clin Invest 2000; 106: 541–550
   PubMed Web of Science ®Google Scholar
• Kunisaki M, Bursell S E, Umeda F, Nawata H, King G L. Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured smooth muscle cells exposed to elevated glucose levels. Diabetes 1994; 43: 1372–1377
   PubMed Web of Science ®Google Scholar
• Kunisaki M, Bursell S E, Clermont A C, Ishii H, Ballas L, Jirousek M R, Umeda F, Nawata H, King G L. Vitamin E treatment prevents diabetes-induced abnormality in retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 1995; 269: E239–E246
   PubMedGoogle Scholar
• Koya D, Lee I K, Ishii H, Kanoh H, King G L. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol 1997; 8: 426–435
   PubMed Web of Science ®Google Scholar
• Keegan A, Walbank H, Cotter M A, Cameron N E. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 1995; 38: 1475–1478
   PubMed Web of Science ®Google Scholar
• Timimi F K, Ting H H, Haley E A, Roddy M A, Ganz P, Creager M A. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998; 31: 552–557
   PubMedGoogle Scholar
• Bursell S E, Clermont A C, Aiello L P, Aiello L M, Schlossman D K, Feener E, Laffel L, King G L. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type I diabetes. Diabetes Care 1999; 22: 1245–1251
   PubMed Web of Science ®Google Scholar
• Grant M B, Ellis E A, Caballero S, Mames R N. Plasminogen activator inhibitor-1 over-expression in nonproloferative diabetic retinopathy. Exp Eye Res 1996; 63: 233–244
   PubMed Web of Science ®Google Scholar
• Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994; 43: 426–429
   PubMedGoogle Scholar
• Skrha J, Hodinar A, Kvasnicka J, Hilgertova J. Relationship of oxidative stress and fibrinolysis in diabetes mellitus. Diabetes Med 1996; 13: 800–805
   Google Scholar
• Feng D, Bursell S E, Clermont A C, Lipinska I, Aiello L P, Laffel L, King G L, Tofler G H. von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care 2000; 23: 1694–1698
   Google Scholar
• The PKC-DRX Study Group. The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative retinopathy. Diabetes 2005; 54: 2188–2197
   Google Scholar
• Aiello L P, Clermont A, Arora V, Davis M D, Sheetz M J, Bursell S E. Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients. Invest Ophthalmol Vis Sci 2006; 47: 86–92
   PubMed Web of Science ®Google Scholar
• Aiello L P, Bursell S E, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulla T A, Ways K, Jirousek M, Smith L E, King G L. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997; 46: 1473–1480
   PubMed Web of Science ®Google Scholar
• Danis R P, Bingaman D P, Jirousek M, Yang Y. Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKC-β : inhibition with LY333531. Invest Ophthalmol Vis Sci 1998; 39: 171–179
   PubMed Web of Science ®Google Scholar